" /> Psychotropic medication pharmacogenomic analysis:Find:Pt:Bld/Tiss:Doc:Molgen - CISMeF





Preferred Label : Psychotropic medication pharmacogenomic analysis:Find:Pt:Bld/Tiss:Doc:Molgen;

LOINC status : ACTIVE;

LOINC display name : Psychotropic medication pharmacogenomic analysis Molgen Doc (Bld/Tiss);

LOINC long common name : Psychotropic medication pharmacogenomic analysis in Blood or Tissue by Molecular genetics method;

LOINC short name : Psychotropic Pharmg Analy Bld/T;

LOINC description : A comprehensive analysis for multiple genes that have strong pharmacogenomic associations with medications used in the treatment of psychiatric disorders, including depression. Each sample is tested for specific genetic variations with known functional impact. Depending on the lab, this test may include targeted analysis for following genes: ANKK1, ADRA2, CHRNA3, COMT, CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP3A4, CYP3A5, DRD2, EPHX1, GRIK4, HLA-A (such as HLA-A*31:01 allele), HLA-B (such as HLA-B*15:02 allele), HTR2A, HTR2C, MTHFR, OPRM1, SCN1A, SLC6A4 (5-HTT), and UGT2B15. Duplications and multiplications of alleles may also be identified. Various genotyping assay methods, such as real-time PCR, sequencing, and deletion/duplication analysis, may be used.;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.